M, S., & G, S. (2011). Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: Patient and cost-effectiveness considerations. Dove Medical Press.
Style de citation Chicago (17e éd.)M, Scolnik, et Singh G. Combination Therapy Versus Celecoxib, a Single Selective COX-2 Agent, to Reduce Gastrointestinal Toxicity in Arthritic Patients: Patient and Cost-effectiveness Considerations. Dove Medical Press, 2011.
Style de citation MLA (8e éd.)M, Scolnik, et Singh G. Combination Therapy Versus Celecoxib, a Single Selective COX-2 Agent, to Reduce Gastrointestinal Toxicity in Arthritic Patients: Patient and Cost-effectiveness Considerations. Dove Medical Press, 2011.
Attention : ces citations peuvent ne pas être correctes à 100%.